# Placebo and nocebo in clinical practice: An online cross-sectional survey of healthcare professionals from European countries on views, practices and training needs

**Authors:** Mary O’Keeffe, Nathan Skidmore, Arianna Bagnis, Przemysław Bąbel, Elżbieta A. Bajcar, Alessandra De Palma, Andrea W.M. Evers, Eveliina Glogan, Julia W. Haas, Stefanie H. Meeuwis, Marek Oleszczyk, Antonio Portolés, Johan W.S. Vlaeyen, Katia Mattarozzi, Vilfredo De Pascalis, Vilfredo De Pascalis, Vilfredo De Pascalis, Vilfredo De Pascalis

PMC · DOI: 10.1371/journal.pone.0338905 · PLOS One · 2026-01-14

## TL;DR

Healthcare professionals in Europe often use placebo effects but lack formal training, highlighting a need for better education on placebo and nocebo effects.

## Contribution

Identifies a critical gap in healthcare education regarding placebo and nocebo effects and proposes targeted training solutions.

## Key findings

- 71.7% of healthcare professionals reported using placebo effects in practice.
- Most participants had not received formal training on placebo and nocebo effects.
- Over half of participants observed nocebo effects in their work.

## Abstract

Placebo and nocebo effects significantly influence health outcomes, yet healthcare professionals receive limited training and guidance on their mechanisms and clinical application, creating a gap in education and practical understanding. Conducted within the European PANACEA Consortium, this study evaluated healthcare professionals’ knowledge, attitudes, and practices regarding placebo and nocebo effects, and assessed their needs in further education.

An online cross-sectional survey among a European multi-country convenience sample of healthcare professionals collected data assessing participants’ knowledge, perceptions, and experiences regarding placebo and nocebo effects; their application and ethical considerations in clinical practice; and investigated educational needs and interest in further training. Quantitative data were analyzed using descriptive statistics, and thematic analysis was applied to the free-text responses.

Amongst 807 participants, 71.7% reported taking advantage of placebo effects in their practice, and over half of participants (55.8%) observing nocebo effects. Participants reported feeling somewhat confident (53.3%) in harnessing placebo effects with 47.5% feeling confident in preventing nocebo effects. The majority of respondents had not received formal training on placebo and nocebo effects, with most expressing an interest in further training in areas such as healthcare education, emphasizing communication skills to enhance placebo effects, and knowledge to recognize and reduce nocebo effects.

There is a significant need for more comprehensive training on placebo and nocebo effects, particularly in early health professional education. These findings informed the development of educational resources and best practice recommendations developed as part of the outcomes from the PANACEA Consortium, improving the understanding and application of these effects among healthcare professionals across Europe.

## Full-text entities

- **Diseases:** Pain (MESH:D010146), anxiety (MESH:D001007), viral infections (MESH:D014777), functional disorders (MESH:D003291), fatigue (MESH:D005221)
- **Chemicals:** PONE-D-25-28687R2 (-), sugar (MESH:D000073893)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12834211/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12834211/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12834211/full.md

---
Source: https://tomesphere.com/paper/PMC12834211